Definitive Contract W911NF20C0051
Award Date 9/28/20
Potential Completion Date 9/27/22
Potential Value $473K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a $998,717.00 firm fixed-price contract awarded by the United States Special Operations Command to Cellphire, Inc., a small business biotechnology company, to provide freeze-dried plasma for canines. The contract was set aside for total small business participation. Cellphire has past experience providing research, development, and manufacturing services for lyophilized canine plasma and cryopreserved human platelets through prime contracts with the Department of the Army and Defense...
- The Department of the Army Medical Command awarded a $148,203.61 Small Business Innovation Research (SBIR) Phase I contract to Haima Therapeutics LLC, a woman-owned small business, for research and development of a nanotechnology-enabled biosynthetic whole-blood surrogate for hemostatic resuscitation. This contract supports the Congressionally Directed Medical Research Programs' Combat Readiness-Medical Research Program under a Rapid Development and Translational Research Award. Additionally,...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Sigma Genetics Inc., a for-profit organization located in Seattle, WA. The contract, valued at $64,111.00, is for advancing battlefield and global blood supply solutions through novel magnetoporation techniques to create functional lyophilized (freeze-dried) red blood cells with superior trehalose delivery. This research aims to improve the preservation and...
- <p>This is a $146,094.30 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Special Operations Command (USSOCOM) to Oxford Biomedical Research, Inc. The contract is for a feasibility study on the topic of "FREEZE DRIED PLASMA FOR CANINES" under SOCOM SBIR Topic 163-007. The contract has a period of performance through July 5, 2017 and is a firm-fixed-price purchase order.</p>
- The U.S. Defense Health Agency awarded a $2,540,072.75 cost-plus-fixed-fee definitive contract to Bodevet, Inc., a self-certified small disadvantaged business, for a clinical trial in support of trauma indications for lyophilized canine blood products. The contract has an ultimate completion date of July 31, 2024 and was awarded on May 1, 2020. The contract is not set aside for any special designation. This award supports the Defense Health Agency's research and development efforts related to...
- The Defense Health Agency awarded a $9.7 million firm fixed price contract to Vascular Solutions LLC (a Teleflex Medical division) on September 9, 2020, for freeze dried plasma commercial viability activities. The contract, which extends through December 31, 2025, supports the development and commercialization of freeze dried plasma products and related activities. The work is being performed in Maple Grove, Minnesota, and no set-aside designation was used for this award. This contract...
- This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
- This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
- This is a $999,877.89 Cost Plus Fixed Fee contract awarded by the Defense Health Agency to CFD Research Corporation, a small business, under the SBIR Phase II program. The contract is titled "Systems Biology Based Tools for Modeling Platelet Storage Lesion for Optimal Blood Transfusion" and is focused on developing computational tools to model platelet storage for improved blood transfusion. CFD Research Corporation is a small business specializing in engineering simulations and...
- The Department of the Army Medical Command awarded a $249,337.43 firm-fixed-price purchase order to Delta Development Team, Inc., a self-certified small disadvantaged business, for medical research and development services under the SBIR (Small Business Innovation Research) program Phase I. The contract work is focused on battlefield solutions and technologies, including projects such as the development of a maturing battlefield whole blood logistics solution, medical equipment for national...